Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis

Recruiting N/A Interventional Study
Anal Cancer Squamous Intraepithelial Lesions HSIL, High Grade Squamous Intraepithelial Lesions LSIL, Low-Grade Squamous Intraepithelial Lesions HPV Squamous Cell Carcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 and older
Sex
Male
Study type
Interventional
Purpose
Screening
Participants needed
296 (estimated)
Sponsor
Universitair Ziekenhuis Brussel · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to learn more about anal cancer risk in men who have sex with men (MSM) who are using Pre-Exposure Prophylaxis (PrEP) to prevent HIV. Specifically, we want to check how common High-Grade Squamous Intraepithelial Lesions (HSIL) are in this group, how well anal swabs can screen for these lesions, and how having HSIL affects their quality of life. We'll also test if DNA methylation te…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * HIV-uninfected MSM (men who have sex with men) aged 35 years or older. * participants must have been using PrEP for at least 3 months. * Dutch, English or French speaking and writing Exclusion Criteria: * Any intervention in the (peri-)anal region within the past 3 months * …
Contacts

Magali Surmont

024776001

magali.surmont@uzbrussel.be

CONTACT